Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Pharma giant Pfizer has opted to retain Carat as its media agency after a review, the company has confirmed.
The company spent $1.3 billion on ads in 2009, and $600 million during the first six months of this year, according to Nielsen.
The review marks the second big pharma reassessment handed down in as many days. Yesterday, GlaxoSmithKline opted to switch shops after a review, awarding its $700 million U.S. assignment to Omicom’s PHD. WPP’s MediaCom was the incumbent.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in